Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.


Autoria(s): Copland, D.A.; Hussain, K.; Baalasubramanian, S.; Hughes, T.R.; Morgan, B.P.; Xu, Heping; Dick, A.D.; Nicholson, L.B.
Data(s)

01/03/2010

Identificador

http://pure.qub.ac.uk/portal/en/publications/systemic-and-local-antic5-therapy-reduces-the-disease-severity-in-experimental-autoimmune-uveoretinitis(9f3c4620-29a5-4800-9c15-74cf65b151c1).html

http://dx.doi.org/10.1111/j.1365-2249.2009.04070.x

http://www.scopus.com/inward/record.url?scp=74549136857&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Copland , D A , Hussain , K , Baalasubramanian , S , Hughes , T R , Morgan , B P , Xu , H , Dick , A D & Nicholson , L B 2010 , ' Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. ' Clinical and Experimental Immunology , vol 159 , no. 3 , pp. 303-314 . DOI: 10.1111/j.1365-2249.2009.04070.x

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2400/2403 #Immunology #/dk/atira/pure/subjectarea/asjc/2700/2723 #Immunology and Allergy
Tipo

article